Aperion Biologics Corporation - Product Pipeline Analysis, 2016 Update

Date: February 3, 2016
Pages: 26
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A5EF6E4CD9BEN
Leaflet:

Download PDF Leaflet

Aperion Biologics Corporation - Product Pipeline Analysis, 2016 Update
Summary

Aperion Biologics Corporation (Aperion Biologics), formerly CrossCart, Inc. is a medical device company that develops and commercializes animal-based tissue technology. The company’s products include ligament reconstruction. Aperion Biologics’ Z-Process of humanizing and sterilizing tissue can be applicable to tissues from orthopedic ligaments, bone, and meniscus to valves and vessels to soft tissue grafts for augmentation and repair. The company’s Z-Lig is a porcine-derived ACL reconstruction alternative. It concentrates on regenerative medicine with a technology which provides a solution to the surgical need for human based grafts from alternative source of tissue. The company has presence in the US and other European markets. Aperion Biologics is headquartered in San Antonio, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Aperion Biologics Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Aperion Biologics Corporation Company Snapshot
Aperion Biologics Corporation Company Overview
Key Information
Aperion Biologics Corporation Pipeline Products and Clinical Trials Overview
Aperion Biologics Corporation - Major Products and Services
Aperion Biologics Corporation Pipeline Products by Development Stage
Aperion Biologics Corporation Clinical Trials by Trial Status
Aperion Biologics Corporation Pipeline Products Overview
Z-Lig ACLR
Z-Lig ACLR Product Overview
Z-Lig ACLR Clinical Trial
Z-Lig BT
Z-Lig BT Product Overview
Z-Lig BTB
Z-Lig BTB Product Overview
Z-Lig ST
Z-Lig ST Product Overview
Aperion Biologics Corporation - Key Competitors
Aperion Biologics Corporation - Key Employees
Aperion Biologics Corporation - Locations And Subsidiaries
Head Office
Recent Developments
Aperion Biologics Corporation, Recent Developments
Apr 22, 2014: Aperion Biologics Granted CE Mark for Z-Lig ACL Replacement Device
Mar 11, 2014: France Dixon Helfer and Mike Ward Appointed to the Board of Directors of Aperion Biologics
Mar 28, 2012: Aperion Biologics Completes Enrollment In Z-Lig ACLR Medical Device Performance Trial
Sep 14, 2011: Aperion Biologics Reaches Midpoint Of Enrollment In Z-Lig Anterior Cruciate Ligament Reconstruction Medical Device Performance Trial
Feb 11, 2011: Aperion Biologics Initiates Clinical Trial Of Z-Lig Device For Anterior Cruciate Ligament Reconstruction
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Aperion Biologics Corporation, Key Facts
Aperion Biologics Corporation Pipeline Products and Clinical Trials Overview
Aperion Biologics Corporation Pipeline Products by Equipment Type
Aperion Biologics Corporation Pipeline Products by Indication
Aperion Biologics Corporation Clinical Trials by Trial Status
Aperion Biologics Corporation, Major Products and Services
Aperion Biologics Corporation Number of Pipeline Products by Development Stage
Aperion Biologics Corporation Pipeline Products Summary by Development Stage
Aperion Biologics Corporation Clinical Trials by Trial Status
Aperion Biologics Corporation Clinical Trials Summary
Z-Lig ACLR - Product Status
Z-Lig ACLR - Product Description
Z-Lig ACLR - A Prospective, Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of the Z-Lig Medical Device Compared to Allograft for the Reconstruction of Ruptured Anterior Cruciate Ligaments
Z-Lig BT - Product Status
Z-Lig BT - Product Description
Z-Lig BTB - Product Status
Z-Lig BTB - Product Description
Z-Lig ST - Product Status
Z-Lig ST - Product Description
Aperion Biologics Corporation, Key Employees

LIST OF FIGURES

Aperion Biologics Corporation Pipeline Products by Equipment Type
Aperion Biologics Corporation Pipeline Products by Development Stage
Aperion Biologics Corporation Clinical Trials by Trial Status
Skip to top


Ask Your Question

Aperion Biologics Corporation - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: